Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Annual account missing NBB
Fiscal year 2024 was expected before 31 July 2025 and has not been filed.
Financials
Financial year 2023
LT Pharma from Floreffe, company number BE0662445167, closed financial year 2023 with a result of € 122,899 after tax. For that financial year LT Pharma recorded a gross margin of € 179,422 and equity of € 1.1 million. Compared with financial year 2022, the result moved from € 126,852 to € 122,899. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2024.
€ 1.1 million
▲ 12% vs 2022
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 122,899
▼ 3% vs 2022
Profit after tax over the fiscal year.
€ 540,978
▼ 4% vs 2022
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2023. Retained profit grew to € 1.1 million.
People and assets in 2023
€ 5,105
▼ 59% vs 2022
Book value of vehicles, furniture and equipment.
Debts at end 2023
€ 559,808
▼ 10% vs 2022
€ 60,584 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.
€ 2,794
▲ 34% vs 2022
Supplier invoices still open on the last day of the fiscal year.
€ 1,424
▲ 120% vs 2022
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | Change 2022 → 2023 | |
|---|---|---|---|---|
| Gross margin | € 113,214 | € 182,138 | € 179,422 | ▼ 1% |
| Profit after taxes | € 74,926 | € 126,852 | € 122,899 | ▼ 3% |
| Equity | € 867,440 | € 994,292 | € 1,117,191 | ▲ 12% |
| Total debts | € 702,665 | € 626,590 | € 566,283 | ▼ 10% |
| Cash | € 200,906 | € 561,322 | € 540,978 | ▼ 4% |
| Retained profit | € 848,840 | € 975,692 | € 1,098,591 | ▲ 13% |
| Bank debt | € 678,944 | € 619,038 | € 559,808 | ▼ 10% |
| Balance sheet total | € 1,570,105 | € 1,620,882 | € 1,683,474 | ▲ 4% |
Key figures of LT Pharma, fiscal years 2021 to 2023, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2024 has not been filed yet; it was expected before 31 July 2025.
What happened to LT Pharma?
What happened at LT Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2023: profit of € 122,899 (▼ 3% vs 2022). filed late Source: NBB ↗
- New establishment in Floreffe. KBO
- Start of the company according to the CBE. KBO
In short
From € 74,926 profit in 2021 to € 122,899 profit in 2023.
Paid € 94,960 in corporate taxes since 2021.
Best year ever: 2022, with € 126,852 profit.
A new publication or filing at LT Pharma? We notify you, reason included.
Follow LT PharmaDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Establishments
Establishment units
Physical locations of this company
Rue de Robersart, Franière 29
5150 Floreffe
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0662.445.167
- VAT number
- BE 0662.445.167
- Registered office
- Rue de Robersart, Franière 29, 5150 Floreffe
- Names & denominations
- LT Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 8 September 2016
- Peppol
- Active · Active since 17 Dec 2025
- Contact
- [email protected] +32486528723
- Activities · NACE
Detailhandel in farmaceutische producten